Cardioprotective effect of IGF-1 against myocardial ischemia/reperfusion injury through activation of PI3K/Akt pathway in rats in vivo
Authors:
Open Access
- 25 July 2019
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (8) , 3886-3897
Abstract
Objective: It remains unknown whether insulin-like growth factor-1 (IGF-1) can attenuate myocardial ischemia/reperfusion (I/R) injury in vivo by activating the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) pathway. This study investigated the possible interaction of IGF-1 with the PI3K/Akt pathway in cardioprotection against in vivo myocardial I/R injury in rats. Methods: We established a myocardial I/R model in rats through left anterior descending artery ligation for 40 minutes followed by 6 hours reperfusion. The PI3K/Akt inhibitor, LY294002 (0.3 mg/kg), was injected through the caudal vein 30 minutes before myocardial ischemia, and IGF-1 (1 µg/kg or 5 µg/kg) was injected through the caudal vein 10 minutes before myocardial ischemia. Results: IGF-1 treatment decreased myocardial infarct size; myocardial cell apoptosis; and serum lactate dehydrogenase, creatine kinase MB, and cardiac troponin I levels in rats with myocardial I/R in vivo . Moreover, IGF-1 treatment led to significant increases in expression levels of p-Akt (Ser473) and B cell lymphoma 2, while reducing expression levels of caspase-9 mRNA and cleaved caspase-9 protein in rats with myocardial I/R. However, pretreatment with LY294002 significantly reduced the cardioprotective effects of IGF-1. Conclusion: Treatment with IGF-1 may confer cardiac protection against in vivo myocardial I/R injury via the PI3K/Akt pathway in rats.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2016A030310190)
- National Natural Science Foundation of China (81600396)
This publication has 39 references indexed in Scilit:
- Cardioprotection of Insulin-Like Growth Factor-1 During Reperfusion TherapyCirculation: Cardiovascular Interventions, 2011
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Apoptosis and the cardiac action of insulin-like growth factor IPharmacology & Therapeutics, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Bcl-2 family members and apoptosis, taken to heartAmerican Journal of Physiology-Cell Physiology, 2007
- Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and AktJournal of Molecular and Cellular Cardiology, 2005
- Molecular mechanisms of caspase regulation during apoptosisNature Reviews Molecular Cell Biology, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- In Cardiomyocyte Hypoxia, Insulin-Like Growth Factor-I-Induced Antiapoptotic Signaling Requires Phosphatidylinositol-3-OH-Kinase-Dependent and Mitogen-Activated Protein Kinase-Dependent Activation of the Transcription Factor cAMP Response Element-Binding ProteinCirculation, 2001
- Adenoviral Gene Transfer of Activated Phosphatidylinositol 3′-Kinase and Akt Inhibits Apoptosis of Hypoxic Cardiomyocytes In VitroCirculation, 1999